EPHA4 and amyotrophic lateral sclerosis: Overall, our results with inducible EphA4 KO in SOD1G93A mice, despite caveats due to limitations of the model, when taken along with a growing body of evidence, raise significant concerns for the therapeutic hypothesis that EphA4 inhibition would be beneficial in ALS.